Acción 1302 LIFETECH SCIENTIFIC CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas LifeTech Scientific Corporation

Acciones

1302

KYG548721177

Diferido Hong Kong S.E.
Otros sitios de cotización
 07:41:49 26/06/2024 		Varia. Cinco días. Varia. 1 de enero.
1,43 HKD +0,70 % Gráfico intradía de LifeTech Scientific Corporation -6,54 % -39,15 %
16/05 LifeTech Scientific completa el seguimiento del estudio clínico de fase II del andamio coronario IBS MT
15/05 LifeTech Scientific Corporation anuncia los resultados del seguimiento al año del estudio clínico de fase II del sistema de andamiaje coronario biorreabsorbible de hierro liberador de sirolimus IBS CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold
LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
Lifetech Scientific Buys Shares For Employee Incentive Scheme
Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits
LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
LifeTech Scientific Flags Significant Profit Drop in 2023
Lifetech Scientific Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
LifeTech Scientific to Grant 174.8 Million Share Options
LifeTech Scientific Gets Regulatory Nod to Register Peripheral Thrombus Aspiration Catheter
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results
LifeTech Scientific's H1 Attributable Profit Grows on Higher Revenue
LifeTech Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
China Grants Official Registration Approval for LifeTech Scientific's Surgical Navigation System
Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA
Jenscare Scientific, LifeTech Complete Treatment for Valve Replacement Product; Jenscare Shares Rise 3%
LifeTech Scientific Unit Invests 50 Million Yuan in Structured Deposit Product by Bank of Ningbo
LifeTech Scientific Completes Patient Enrollment for Phase 3 Study of Coronary Scaffold System
Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of Ibs®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 1302
  4. Noticias LifeTech Scientific Corporation
  5. Otros idiomas